Home - Clinical Trials Arena
Migraine in Major Markets, Disease Management, Epidemiology, Pipeline Asses... $10995. M&A in the Contract Manufacturing Industry: Implications and Outlook - ... $4995. Cell & gene therapy in pharma: CAR-T cell based therapies... $250. 1 of 2.
Mounjaro (tirzepatide) for the Treatment of Type 2 Diabetes, USA
Jun 19, 2024 · Mounjaro ™ (tirzepatide) is a dual-targeted, injectable, sustained-release therapy indicated for the treatment of type 2 diabetes (T2D) in adults as an adjunct to diet and exercise.. Developed by Eli Lilly, a pharmaceutical company based in the US, Mounjaro is the first and only once-weekly glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor ...
News - Clinical Trials Arena
News - Clinical Trials Arena. Adapting diabetes clinical trials to embrace underrepresented communities. Mapping out strategies to overcome challenges in clinical research. Reeves’ 2024 budget promises life sciences investment. Q2 2024 update: social responsibility related hiring actvity in the pharma industry.
Hepatitis B: Four trials to watch over the next 12 months
Jul 28, 2023 · Hepatitis B immune globulin (Hepatect, Nabi-HB, Zutectra, Neohepatect, Fovepta) contains mainly immunoglobulin G and acts as passive immunising preparation. The two cohorts are HBsAg positive and HBeAg negative, with one group having had no treatment while the other group will have been treated with anti-HBV NUC for at least 12 months before ...
Obesity: Six trials to watch over the next 12 months
Jun 30, 2023 · According to a report by GlobalData, the market for obesity drugs is predicted to be worth $37.1bn in 2031. GlobalData is a parent company of the Clinical Trials Arena. As more trials take place globally, not only will this help to provide a wider range of treatments for patients but will also assist the unmet need of lack of supply.
Top Ongoing mRNA Herpes Vaccine Trials - Clinical Trials Arena
Feb 2, 2023 · Pfizer and Moderna eye seasonal influenza. The two largest mRNA vaccine trials with readouts in 2023 are for seasonal influenza. First up, Moderna’s 6,102-patient, Phase III trial of mRNA-1010 (NCT05415462) has immunogenicity data expected in Q1 2023. The trial is testing mRNA-1010 against an active comparator vaccine, with primary endpoints ...
Contract Research Organizations for the Clinical Trials Industry
Within the healthcare industry, CROs offer a range of services for various stages of product development, clinical trial, review and marketing. Some of the current industry leading services include, without necessarily being limited to: Formulation expertise in the research and development stage. Preclinical and clinical studies stage: site ...
CRO consolidation: is the clinical trials industry reaching a tipping ...
Nov 2, 2022 · Labcorp announced the spinoff of its drug development and clinical trials arm in August 2022, called Clinical Development Business, which will now operate as a CRO offering Phase I–IV clinical trial management and technology to the biopharma industry. Labcorp will retain the laboratory business that is related to routine and esoteric labs ...
HIV: Three trials to watch in 2024 - Clinical Trials Arena
Dec 18, 2023 · The Phase IIa trial (NCT05947890) is investigating the safety and immunogenicity of the vaccine candidate and primary completion is scheduled for November 2024. The study plans to enrol 276 patients and it will be conducted in two parts, A and B. Part A will include two cohorts; each cohort will have four groups.
Oral Covid vaccine: can Vaxart overcome clinical trial obstacles?
Nov 24, 2021 · Vaxart’s Covid-19 vaccine tablet has a coating that allows it to withstand the low pH in the stomach. Credit: Vaxart. Vaxart is aiming to be a vital player in boosting vaccination rates with its oral Covid-19 vaccine. There is still unmet need, with only 53% of the world’s population receiving at least one dose of a Covid-19 vaccine.